ImmunityBio, Inc. (IBRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ImmunityBio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.18x | -4.32x | -4.38x | -4.87x | -6.82x | -23.02x |
| P/B Ratio | -3.65x | -3.65x | -4.35x | -4.53x | -9.77x | -42.63x |
| P/S Ratio | 16.08x | 121.07x | 4105.07x | 8447.89x | 2533.77x | 8442.61x |
| Profitability | ||||||
| Gross Margin | 99.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -36509.1% |
| Net Margin | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -36669.6% |
| EBITDA Margin | -197.3% | -1793.4% | -76955.5% | -146617.1% | -34341.8% | -33755.4% |
| Liquidity | ||||||
| Current Ratio | 5.10x | 3.36x | 5.05x | 0.28x | 0.91x | 1.64x |
| Quick Ratio | 5.08x | 3.21x | 5.05x | 0.28x | 0.91x | 1.64x |
| Leverage | ||||||
| Debt/Equity | -1.76x | -1.03x | -1.24x | -1.62x | -2.67x | -2.30x |
YoY = year-over-year change. Source: FMP..